Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Arixtra“
Suchtreffer
Begriffe & Kennungen
Arixtra · 4.4 Special warnings and precautions for use · 5
Eintrag öffnenArixtra · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenArixtra · 4.5 Interaction with other medicinal products and other forms of interaction · 2
Eintrag öffnenArixtra · 4.5 Interaction with other medicinal products and other forms of interaction · 3
Eintrag öffnenArixtra · 4.5 Interaction with other medicinal products and other forms of interaction · 4
Eintrag öffnenArixtra · 4.5 Interaction with other medicinal products and other forms of interaction · 5
Eintrag öffnenArixtra · 4.5 · 32 Platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam) and digoxin did not interact with the pharma
Eintrag öffnenArixtra · 4.5 · 44 Platelet inhibitors (acetylsalicylic acid), NSAIDs (piroxicam) and digoxin did not interact with the pharma
Eintrag öffnenArixtra · 4.5 · 56 not influence the bleeding time under acetylsalicylic acid or piroxicam treatment, nor the pharmacokinetics
Eintrag öffnenArixtra · 4.5 · Bleeding risk is increased with concomitant administration of fondaparinux and agents that may enhance the ris
Eintrag öffnenArixtra · 4.5 · Bleeding risk is increased with concomitant administration of fondaparinux and agents that may enhance the ris
Eintrag öffnenArixtra · 4.5 · Bleeding risk is increased with concomitant administration of fondaparinux and agents that may enhance the ris
Eintrag öffnenArixtra · 4.5 · Bleeding risk is increased with concomitant administration of fondaparinux and agents that may enhance the ris
Eintrag öffnenArixtra · 4.5 · Bleeding risk is increased with concomitant administration of fondaparinux and agents that may enhance the ris
Eintrag öffnenArixtra · 4.5 · Follow-up therapy with another anticoagulant medicinal product If follow-up treatment is to be initiated with
Eintrag öffnenArixtra · 4.5 · Follow-up therapy with another anticoagulant medicinal product If follow-up treatment is to be initiated with
Eintrag öffnenArixtra · 4.5 · If follow up treatment with a Vitamin K antagonist is required, treatment with fondaparinux should be continue
Eintrag öffnenArixtra · 4.5 · In clinical studies performed with fondaparinux, oral anticoagulants (warfarin) did not interact with the phar
Eintrag öffnenArixtra · 4.5 · In clinical studies performed with fondaparinux, oral anticoagulants (warfarin) did not interact with the phar
Eintrag öffnenArixtra · 4.5 · In clinical studies performed with fondaparinux, oral anticoagulants (warfarin) did not interact with the phar
Eintrag öffnen